UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Methylation analysis in spontaneous sputum for lung cancer diagnosis

Lung cancer (Amsterdam, Netherlands), 2014-05, Vol.84 (2), p.127-133

2014

Volltextzugriff (PDF)

Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

Lung cancer (Amsterdam, Netherlands), 2010-06, Vol.68 (3), p.309-318

2010

Volltextzugriff (PDF)

Retraction notice to “Aberrant methylation of Reprimo in lung cancer” [Lung Cancer 47 (2005) 309–314]

Lung cancer (Amsterdam, Netherlands), 2014-08, Vol.85 (2), p.337-337

2014

Volltextzugriff (PDF)

Aberrant methylation of Reprimo in lung cancer

Lung cancer (Amsterdam, Netherlands), 2005-03, Vol.47 (3), p.309-314

2005

Volltextzugriff (PDF)

RETRACTED: Aberrant methylation of Reprimo in lung cancer

Lung cancer (Amsterdam, Netherlands), 2005-03, Vol.47 (3), p.309-314

2005

Volltextzugriff (PDF)

O-81 Influence of gender on tobacco exposure related TP53 gene mutations in lung cancer: Analysis of the International Agency for research on cancer (IARC) data base

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S26-S27

2003

Volltextzugriff (PDF)

E-30. The hallmarks of lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S39-S39

2003

Volltextzugriff (PDF)

Genetics of preneoplasia and lung cancer development

Lung cancer (Amsterdam, Netherlands), 1999-09, Vol.25, p.S2-S3

Gazdar, Adi F.

1999

Volltextzugriff (PDF)

E-90. Molecular pathology of small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S109-S109

2003

Volltextzugriff (PDF)

P-308 Epigenetic down regulation of death associated protein kinase in lung cancers

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S170-S170

2003

Volltextzugriff (PDF)

P-290 Aberrant promoter hypermethylation of RUNX3 in non-small cell lung cancer confers adverse prognosis

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S165-S165

2003

Volltextzugriff (PDF)

P-295 Dramatically different roles for caveolin-1 in the development of Non-Small Cell Lung Cancer (NSCLC) vs. Small Cell Lung Cancer (SCLC)

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S166-S166

2003

Volltextzugriff (PDF)

DNA mismatch binding in human lung tumor cell lines

Lung cancer (Amsterdam, Netherlands), 1999-10, Vol.26 (1), p.15-25

1999

Volltextzugriff (PDF)

P-287 Aberrant DNA methylation of the hDAB2IP gene in the promoter region in lung carcinomas

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S164-S165

2003

Volltextzugriff (PDF)

P-309 Aberrant methylation of the tumor necrosis factor related apoptosis inducing ligand decoy receptor genes in malignant mesothelioma and lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S170-S170

2003

Volltextzugriff (PDF)

O-175 Frequent loss of expression of tumor invasion genes integrin, TIMP4 and LN5 in lung cancer via epigenetic and non-epigenetic mechanisms

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S52-S53

2003

Volltextzugriff (PDF)

Telomerase dysregulation during the multistage pathogenesis of lung cancer

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.40-40

1997

Volltextzugriff (PDF)

Proposal for WHO histological typing of lung tumors: Adenocarcinoma and related tumors

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.14-14

1997

Volltextzugriff (PDF)

Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin

Lung cancer, 1993, Vol.9, p.S21-S26

1993

Volltextzugriff (PDF)

A novel 95 kilodalton membrane polypeptide associated with lung cancer drug resistance

Lung cancer, 1993, Vol.9 (1), p.317-326

1993

Volltextzugriff (PDF)

Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance

Lung cancer (Amsterdam, Netherlands), 1994-03, Vol.10, p.S73-S81

1994

Volltextzugriff (PDF)

Molecular genetic changes in the pathogenesis of lung cancer

Lung cancer (Amsterdam, Netherlands), 1994-06, Vol.11, p.256-257

1994

Volltextzugriff (PDF)

Chromosome 3P in small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 1988, Vol.4 (3), p.117-120

1988

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieLung Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(2)

Erscheinungsjahr

n.n

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(23)
Ingenta
(23)
Access via ScienceDirect (Elsevier)
(23)
MEDLINE
(5)
IngentaConnect Journals
(3)

Menü

Weitere Dienste

Einstellungen

Methylation analysis in spontaneous sputum for lung cancer diagnosis

Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

Retraction notice to “Aberrant methylation of Reprimo in lung cancer” [Lung Cancer 47 (2005) 309–314]

Aberrant methylation of Reprimo in lung cancer

RETRACTED: Aberrant methylation of Reprimo in lung cancer

O-81 Influence of gender on tobacco exposure related TP53 gene mutations in lung cancer: Analysis of the International Agency for research on cancer (IARC) data base

E-30. The hallmarks of lung cancer

Genetics of preneoplasia and lung cancer development

E-90. Molecular pathology of small cell lung cancer

P-308 Epigenetic down regulation of death associated protein kinase in lung cancers

P-290 Aberrant promoter hypermethylation of RUNX3 in non-small cell lung cancer confers adverse prognosis

P-295 Dramatically different roles for caveolin-1 in the development of Non-Small Cell Lung Cancer (NSCLC) vs. Small Cell Lung Cancer (SCLC)

DNA mismatch binding in human lung tumor cell lines

P-287 Aberrant DNA methylation of the hDAB2IP gene in the promoter region in lung carcinomas

P-309 Aberrant methylation of the tumor necrosis factor related apoptosis inducing ligand decoy receptor genes in malignant mesothelioma and lung cancer

O-175 Frequent loss of expression of tumor invasion genes integrin, TIMP4 and LN5 in lung cancer via epigenetic and non-epigenetic mechanisms

Telomerase dysregulation during the multistage pathogenesis of lung cancer

Proposal for WHO histological typing of lung tumors: Adenocarcinoma and related tumors

Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin

A novel 95 kilodalton membrane polypeptide associated with lung cancer drug resistance

Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance

Molecular genetic changes in the pathogenesis of lung cancer

Chromosome 3P in small cell lung cancer

Aktive Filter

Suchergebnisse filtern